Your browser doesn't support javascript.
loading
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
El-Khoueiry, Anthony B; Sangro, Bruno; Yau, Thomas; Crocenzi, Todd S; Kudo, Masatoshi; Hsu, Chiun; Kim, Tae-You; Choo, Su-Pin; Trojan, Jörg; Welling, Theodore H; Meyer, Tim; Kang, Yoon-Koo; Yeo, Winnie; Chopra, Akhil; Anderson, Jeffrey; Dela Cruz, Christine; Lang, Lixin; Neely, Jaclyn; Tang, Hao; Dastani, Homa B; Melero, Ignacio.
Afiliação
  • El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: elkhouei@med.usc.edu.
  • Sangro B; Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain.
  • Yau T; University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Crocenzi TS; Providence Cancer Center, Portland, OR, USA.
  • Kudo M; Kindai University Faculty of Medicine, Osaka, Japan.
  • Hsu C; National Taiwan University Hospital, Taipei, Taiwan.
  • Kim TY; Seoul National University Hospital, Seoul, South Korea.
  • Choo SP; National Cancer Center, Singapore.
  • Trojan J; Goethe University Hospital and Cancer Center, Frankfurt, Germany.
  • Welling TH; University of Michigan School of Medicine, Ann Arbor, MI, USA.
  • Meyer T; Royal Free Hospital, London, UK.
  • Kang YK; Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Yeo W; Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Chopra A; Johns Hopkins Singapore International Medical Centre, Singapore.
  • Anderson J; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Dela Cruz C; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Lang L; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Neely J; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Tang H; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Dastani HB; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Melero I; Biomedical Research Network in Oncology (CIBERONC), Pamplona, Spain; Center for Applied Medical Research (CIMA), Pamplona, Spain.
Lancet ; 389(10088): 2492-2502, 2017 Jun 24.
Article em En | MEDLINE | ID: mdl-28434648
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article